For the Inventor, By the Inventor

Enter assignee name

Basel, Switzerland

Novartis Pharma Ag

USPTO Granted Patents = 29

CIPO Patents = 2

EPO Patents = 12

Trademarks = 14

Forward Citations = 465

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

James B Fink (3 out of 25 patents)

Adrian Edward Smith (3 out of 32 patents)

Thomas K Brewer (3 out of 11 patents)

4. Derrick J Parks (3 out of 12 patents)

5. Luis A Dellamary (2 out of 74 patents)

6. John Sylvester Power (2 out of 27 patents)

7. Jon David Tuckwell (2 out of 6 patents)

8. Alessandro M Vannucchi (2 out of 2 patents)

9. Costanza Bogani (2 out of 2 patents)

10. Thomas E Tarara (2 out of 38 patents)

11. Yigal Paul Goldberg (2 out of 14 patents)

12. Kyle A Naydo (2 out of 14 patents)

13. Michael D Winther (2 out of 16 patents)

14. Robert M Platz (2 out of 40 patents)

15. Jeffry G Weers (2 out of 60 patents)

29 patents: Sort by Forward Citations

1. 10762980 - Computer-implemented methods of determining protein viscosity (2020-09-01),

2. 10035850 - Methods for treating neovascular age-related macular degeneration (2018-07-31),

3. 9993480 - mTOR/JAK inhibitor combination therapy (2018-06-12),

4. 9458240 - Anti-BAFFR antibody formulations (2016-10-04),

5. 9358229 - JAK PI3K/mTOR combination therapy (2016-06-07),

6. 8869794 - Aerosolization apparatus with capsule puncturing member (2014-10-28),

7. 8802149 - Systems and processes for spray drying hydrophobic and hydrophilic components (2014-08-12),

8. 8336545 - Methods and systems for operating an aerosol generator (2012-12-25),

9. 8173168 - Dispersible macromolecule compositions and methods for their preparation and use (2012-05-08),

10. 8168223 - Engineered particles and methods of use (2012-05-01),

11. 7964591 - Pyridazine derivatives and their use as therapeutic agents (2011-06-21),

12. 7935723 - Use of organic compounds (2011-05-03),

13. 7862834 - Pharmaceutical formulation comprising a water-insoluble active agent (2011-01-04),

14. 7858594 - Crystalline and amorphous forms of beta-L-2'-deoxythymidine (2010-12-28),

15. 7842688 - Organic compounds (2010-11-30),

Novartis Pharma AG is a global healthcare company that focuses on developing, manufacturing, and marketing innovative pharmaceutical products. With a diverse portfolio of prescription medicines, generics, consumer health, eye care, and animal health products, Novartis aims to improve the lives of patients worldwide. Their commitment to research and development drives constant innovation, delivering breakthrough treatments and therapeutics to address a wide range of medical conditions. Novartis prioritizes scientific discoveries and collaborations to advance medical science and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

29 Patents

#14 in Basel

#438 in Switzerland

#21,868 in the World

Basel, Switzerland

Novartis Pharma Ag

Forward Citations = 465

84 inventors:

James B Fink (3 out of 25 patents)

Adrian Edward Smith (3 out of 32 patents)

Thomas K Brewer (3 out of 11 patents)

4. Derrick J Parks (3 out of 12 patents)

5. Luis A Dellamary (2 out of 74 patents)

Please report any incorrect information to support@idiyas.com

Loading…